# A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin

> **NCT02685345** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 85 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** DS-8500a 25 mg
- **DRUG:** DS-8500a 75 mg
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02685345
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-09
- **Final completion:** 2016-10
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2019-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02685345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02685345, "A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02685345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*